CDR2L and Autoimmunity: In addition, CDR2L has been proposed as the main antigen in PCA-1/Yo autoimmunity, which prompted us to study these antigens across a number of patient groups encompassing known PCA-1/Yo autoimmunity and potential sources of false positives (8, 9).